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CC BY-NC-ND license (http://creativAbstract Background: Diverse treatments are available for different histological types of
thyroid lymphoma: concurrent chemoradiotherapy for diffuse large B cell lymphoma (DLBCL)
and radiotherapy or thyroidectomy for low-grade mucosa-associated lymphoid tissue (MALT)
lymphoma. However, diagnosing lymphomas before operation is difficult, because the diag-
nostic yield of fine-needle biopsies is limited by the rarity of the disease. Therefore, patients
may undergo unnecessary thyroidectomies.
Purpose: To investigate the efficacy of various biopsy procedures and explore indications for
thyroidectomy in patients with primary thyroid lymphomas.
Methods: The demographics, types of biopsy procedures, treatments, and outcome data of pa-
tients diagnosed with primary thyroid lymphoma at Tri-Service General Hospital between 1992
and 2015 were retrospectively collected.
Results: Ten patients received a diagnosis of primary thyroid lymphomas: eight with DLBCL and
two with MALT lymphoma. None of these patients received a definitive diagnosis after fine-
needle aspiration biopsies; however, six patients received their diagnosis and histological-
subtype classification after core-needle biopsies. Before 2004, three patients with DLBCL un-
derwent thyroidectomies for diagnostic purposes and one encountered vocal cord palsy. By
contrast, two patients with localized MALT lymphoma underwent thyroidectomies for treat-
ment, with both experiencing favorable outcomes and prognoses.eclare no conflicts of interest.
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202 S.-Y. Wu et al.Conclusion: Core-needle biopsy is superior to fine-needle biopsy for diagnosing primary thyroid
lymphomas without increasing complications. Thyroidectomy in localized, low-grade MALT
lymphoma of the thyroid can cure the disease and exclude high-grade malignancies in the re-
maining glands. By contrast, DLBCL should be treated with chemotherapy and radiotherapy af-
ter diagnosis through biopsy, and extensive surgery should be avoided.
Copyright ª 2016, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Primary thyroid lymphoma is rare, accounting for <5% of
thyroid malignancies.1 The two distinct histological types of
primary thyroid lymphoma are diffuse large B cell lym-
phoma (DLBCL) and mucosa-associated lymphoid tissue
(MALT) lymphoma.2 Because DLBCL is sensitive to chemo-
therapy and radiotherapy, the general consensus is to avoid
extensive surgery. By contrast, radiotherapy or thyroidec-
tomy is typically used as the initial treatment for localized
MALT lymphoma. Fine-needle aspiration cytology, the most
common initial diagnostic tool used in thyroid malig-
nancies, is difficult to use for diagnosing tumor type, which
is necessary for treatment planning. However, core-needle
biopsy, which is less commonly used in thyroid-gland bi-
opsies, may serve as a substitute to surgical biopsy. This
study investigated the efficacy of various biopsy procedures
and explored indications for thyroidectomy in patients with
primary thyroid lymphoma.2. Methods
We retrospectively surveyed patients diagnosed with pri-
mary thyroid lymphoma at Tri-Service General Hospital
between 1992 and 2015. After receiving approval from the
hospital Institutional Review Board (TSGHIRB: 2-102-05-
108), we collected patient data from medical charts and
the cancer registry database of our hospital. This infor-
mation included sex, age at disease onset, history of
thyroiditis, presence of significant airway compression,
goiter size, lymph node involvement, types of biopsy pro-
cedures, stage of disease, modalities of treatment, major
complications related to treatment, duration of follow-up,
and recurrences. The tumor size and extent of involvement
were assessed through computed tomography (CT).
Ultrasound-guided core-needle biopsies were performed by
radiologists. The extent of thyroid operations varied from
lobectomy to total thyroidectomy. Pathological diagnoses
were made by two pathologists who utilized both hema-
toxylin and eosin, as well as immunochemistry staining to
differentiate lymphoma subtypes from Hashimoto’s
thyroiditis. The staging investigation included blood counts,
blood chemistry, chest and abdominal CT, and bone-
marrow biopsies. Additionally, whole-body gallium scans,
whole-body bone scans, or whole-body positron emission
tomography (PET)/CT was performed in some patients.
Disease stage was classified according to the Ann Arbor
staging system: diseases confined to the thyroid gland wereclassified as stage IE, and those with regional node
involvement were classified as stage IIE. The final follow-up
was conducted until October 31, 2015.
3. Results
Ten patients with primary thyroid lymphoma were identi-
fied. Of these, eight had DLBCL, and two had MALT lym-
phoma. Patient demographics, pathological diagnoses, and
disease stages are listed in Table 1. In total, six women and
four men were identified. The mean age at onset was
67.9 years (range, 54e83 years). All patients developed
rapidly growing neck masses over months, with mean tumor
size of 7.1 cm (range, 3.8e11.4 cm).
Nine patients underwent fine-needle aspiration biopsy
(FNAB); of these, no patient received a definitive diagnosis.
Four patients received a definitive diagnosis only after
thyroidectomy. Of these four patients, three were diag-
nosed with DLBCL and one with MALT lymphoma. After
2004, core-needle biopsy was performed in selected cases,
with six patients undergoing the procedure. Of these, five
received a final diagnosis of DLBCL and one of suspected
low-grade lymphoma, which was confirmed as MALT lym-
phoma through thyroidectomy. No complications were
observed after both fine-needle and core-needle biopsies.
One patient with DLBCL had vocal cord palsy after subtotal
thyroidectomy for the initial diagnostic purpose.
Table 2 lists treatment types, major treatment-related
complications, initial disease stages, and their corre-
sponding outcomes. All patients with DLBCL underwent
chemotherapy with a platinum-based regimen. Three pa-
tients also received adjuvant radiotherapy. Two patients
with MALT lymphoma underwent thyroidectomy as the
primary treatment. Patient five initially underwent a lo-
bectomy, after which the frozen tissue section indicated
benign disease, and he had subsequent completion of a
thyroidectomy and adjuvant radiotherapy, because the
final pathological assessment revealed Hashimoto’s
thyroiditis with marginal cell lymphoma (MALT lymphoma).
Patient 8 underwent subtotal thyroidectomy. Neither Pa-
tient 5 nor Patient 8 underwent chemotherapy.
The mean follow-up period was 58.1 months (range,
5e123 months). Two patients with DLBCL developed recur-
rence. Patient 2 experienced regional recurrence along with
airway compression and tracheocutaneous fistula 10 months
after the operation. The patient was treated with salvage
chemotherapy, with four cycles of EPOCH regimen (VP-16 þ
vincristine þ adriamycin þ methylprednisolone þ cyclo-
phosphamide) and radiotherapy, subsequently resulting in
Table 1 Patient demographics and microscopic diagnoses obtained using various biopsy procedures.
Patient Sex/Age Time of
diagnosis
Size by image
(cm)
Microscopic diagnosisa Extrathyroid
extensionFNAC CNB Surgery
1 F/75 Mar 1992 6  4  4 Malignant d DLBCL No
2 M/54 Sep 2002 7  5  2 Suspected malignancy d DLBCL No
3 F/67 Dec 2004 5.4  5.6  8 Thyroiditis d DLBCL Yes
4 F/72 Aug 2004 5.4  7.2  6.6 Thyroiditis DLBCL d Yes
5 M/72 Jun 2006 4.5  3.5  2.0 Nondiagnostic d MALT lymphoma No
6 M/58 Nov 2010 4.2  4.0  11.4 Suspected malignancy DLBCL d Yes
7 F/73 Jul 2011 3.1  2.5  3.8 d DLBCL d Yes
8 M/64 Sep 2013 5.7  4.5  4.3 Suspected malignancy Suspected MALT
lymphoma
MALT lymphoma No
9 F/61 Jul 2014 4.0  4.8  6.2 Suspected malignancy DLBCL d Yes
10 F/83 Dec 2014 6.1  6.7  11.2 Thyroiditis DLBCL d Yes
CNB Z core-needle biopsy; DLBCL Z diffuse large B cell lymphoma; FNAC Z fine-needle aspiration cytology; MALT Z mucosa-asso-
ciated.
lymphoid tissue lymphoma.
a The microscopic diagnosis was obtained using the following three sampling techniques: FNAC, CNB, and surgery.
Table 2 Treatment modalities and their associated complications and outcomes.
Patient Treatment Major
complications
Initial
stage
Outcome Follow
up (mo.)Surgery Chemotherapy Radiotherapy
1 Lobectomy CHOP No d IE Death due to other causes 41
2 Subtotal thyroidectomy CEpiOP Yes d IE Local recurrence in 10 mo. 123
3 Subtotal thyroidectomy CHOP No Vocal cord palsy IIE NED 123
4 No R-CHOP Yes d IIE Local recurrence in 46 mo. 85
5 Total thyroidectomy No Yes d IE NED 107
6 No R-CHOP No Heart failure IIE NED 52
7 No R-CHOP No Neutropenia IIE Partial remission;
death due to sepsis
12
8 Subtotal thyroidectomy No No No IE NED 25
9 No R-CHOP No No IIE NED 8
10 No R-COP No Neutropenia IIE NED 5
CHOP Z cyclophosphamide þ doxorubicin þ vincristine þ prednisolone; R Z rituximab; CEpiOP Z cyclophosphamide þ epirubicin þ
vincristine þ prednisolone; NED Z no evidence of disease.
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rence, causing acute respiratory failure 46 months after
operation. Pulse-steroid therapy and further radiotherapy
(4500 cGy in total) achieved complete remission. One pa-
tient died from an unrelated medical cause. One patient
with DLBCL experienced partial remission after eight cycles
of the R-CHOP regimen; however, the patient died from
sepsis during salvage chemotherapy.
In Patients 4, 6, 7, and 10 with DLBCL, systemic steroid
therapy immediately relieved airway compression and
precluding the need for tracheostomy. Additionally,
remarkable tumor shrinkage was observed after chemo-
therapy. A comparison of the neck CT scans of Patient 6
before and after treatment is presented in Figure 1.4. Discussion
Primary thyroid lymphoma is rare, accounting for only 5% of
thyroid malignancies and 2% of extranodal lymphomas.Thyroid lymphoma typically presents as a rapidly growing
neck mass that is sometimes accompanied by respiratory
compression symptoms. Thyroid lymphoma is more pre-
dominant in women and has a peak onset age of 50 to
70 years.2e4 The risk of thyroid lymphoma is high in in-
dividuals with a history of chronic thyroiditis, such as
Hashimoto’s thyroiditis.5,6
Similar to other lymphomas, subtypes in thyroid lym-
phoma are classified according to histological and immuno-
logical features. B cell non-Hodgkin’s lymphoma is the most
common subtype, whereas DLBCL and marginal-zone B cell
lymphoma of MALT type (MALT lymphoma) are other com-
mon subtypes that may also co-occur in a single patient2;
follicular, small lymphocytic, and T cell-origin lymphoma are
other less common subtypes of the disease. Ultrasound is a
common diagnostic tool for measuring the thyroid mass,
because it reveals hypoechoic masses intermingled with
echogenic structures and enhances posterior echoes.7 FNAB
is often used as an initial tool for the pathological diagnosis
of the thyroid nodule and can provide a suggestive diagnosis
Figure 1 Neck computed tomography scans of a patient with diffuse large B cell lymphoma. (A) Initially, the significant
enlargement of the thyroid tumor and lymph nodes caused airway compression. (B) After three of six cycles of chemotherapy with
the R-CHOP regimen, tumor regression and airway compression relief was noted. CHOP Z cyclophosphamide þ doxorubicin
plus; vincristine þ prednisolone; R Z rituximab.
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observed as atypical large lymphocytes with frequent
mitosis and reveal positive B cell markers (CD20 and CD79a)
on immunohistochemical staining. By contrast, low-grade
lymphomas are observed as a mixture of small and large
lymphocytes, mimicking Hashimoto’s thyroiditis. In uncer-
tain diagnoses, adjuvant tests, such as immunophenotyping,
flow cytometry,8 and polymerase chain reaction-based
detection of the immunoglobulin heavy chain gene, may
be helpful9; however, because of the rarity of the disease,
availability of these adjuvant tests varies among in-
stitutions, and no universal standard is available.
Accordingly, false-negative results have limited diag-
nostic accuracy to 59% to 88%.10,11 FNAB failed to diagnose
thyroid lymphoma in all nine patients examined in the
current study. This is likely attributable to the inadequate
experience of our cytopathologists resulting from the rarity
of the disease, and we believe most clinicians in low-
volume centers may face similar dilemmas.
In this study, all patients received a final diagnosis after
a core-needle biopsy or thyroidectomy. Biopsy procedures
performed to obtain an adequate specimen remain neces-
sary for our pathologists to differentiate the histological
subtypes of thyroid lymphoma. Five of our patients were
diagnosed using ultrasound-guided core-needle biopsies,
avoiding the need of further surgery for diagnosis. Ultra-
sound imaging is a valuable tool, because it can identify
solid tumor lesions while avoiding necrotic lesions or vessel
injuries. In all thyroid malignancies, the accuracy obtained
using core-needle biopsy was higher (up to 92.1%) than thatobtained using FNAB.12 Histological sub-classification is
possible, because core-needle biopsy successfully sub-
classifies histological types in 89.7% of neck lymphomas.13
This technique provides an adequate amount of specimen
for the detection of prognostic markers, such as Ki-67 and
p53, through immunohistochemistry staining, enabling a
reliable differentiation between Hashimoto’s thyroiditis
and anaplastic carcinoma.14 Considering the indeterminate
results of FNAB, core-needle biopsy can be used as a
complementary diagnostic tool before surgery.12,15
In core-needle biopsy, bleeding is a major concern;
however, no bleeding complication related to needle biopsy
was observed in this study. Studies reported the incidence
of hematoma formation as being slightly higher after core-
needle biopsy (0.02e2.00%) as compared with that
observed after fine-needle biopsy12,15; however, none of
the patients required hospitalization. Additionally, while
the ultrasound-guided core-needle biopsy typically requires
fewer needle passes as compared with those required for
fine-needle biopsy, the adequacy of the specimen is supe-
rior.16 Therefore, ultrasound-guided core biopsy is an effi-
cient and relatively safe alternative to open biopsy for the
diagnosis of thyroid lymphoma.17
The proposed management algorithm for primary thy-
roid lymphoma is presented in Figure 2. In patients with
rapidly growing neck masses and a diffuse infiltrative image
pattern, the differential diagnosis may include anaplastic
carcinoma, poorly differentiated thyroid cancer, and thy-
roid lymphoma. Once initial FNAB fails to definitively di-
agnose the tumor type, core-needle biopsy should be
Surgery for primary thyroid lymphomas 205considered. In patients with a diffuse infiltrative image
pattern or high clinical suspicion of lymphoma, core-needle
biopsy may be used instead of FNAB as an initial diagnostic
test. For example, Patient 7 underwent core-needle biopsy
without undergoing a prior FNAB. The results of the biopsy
revealed DLBCL, precluding the need for any additional
surgical biopsy.
The staging work-up involves physical examination,
laboratory blood tests (complete blood counts and
biochemistry data, including beta-microglobulin and
lactate dehydrogenase values), radiological imaging (CT/
magnetic resonance imaging (MRI) scans and MRI), nuclear
medicine imaging (gallium scan and PET scans), and bone-
marrow examination. CT or MRI scans are valuable in
defining the local extent of the disease, such as a potential
extrathyroid invasion, substernal extension, and lymph
node involvement. In patients suitable for thyroidectomy,
resectability is also ideally evaluated through CT scans toFigure 2 The proposed management algorithm for primary
PDTCZ poorly differentiated thyroid cancer; DLBCLZ diffuse largeassess vascular enhancement or prevertebral fascia inva-
sion18; however, nuclear imaging is more useful for evalu-
ating the extent of lymph node involvement and distant
metastasis. PET-CT scans largely replaced gallium scans at
our institute after 2008, because they provide more precise
localization and provide high sensitivity and specificity for
all lymphoma subtypes, especially those of an indolent
nature (such as MALT and follicular).19 Compared with
nodal non-Hodgkin’s lymphomas, primary thyroid lym-
phoma tends to be less invasive. Most cases of thyroid
lymphoma belong to Ann Arbor stage IE or IIE. The prognosis
is poor for patients with an International Prognostic Index
score 2 (including advanced stage and age), large B cell or
follicular histology, or inadequate local tumor control by
radiation or surgery.2e4,20 Additionally, the histological
findings of vascular invasion, abundant apoptosis, high
mitotic rate, and perithyroidal soft-tissue invasion are
associated with poor prognosis.2thyroid lymphoma. DTC Z differentiated thyroid cancer;
B cell lymphoma; MALTZmucosa-associated lymphoid tissue.
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due to the limited number of cases. Therefore, a single
standard treatment is not available for thyroid lymphoma.
Common treatment regimens are derived from the treat-
ment of extranodal lymphomas. Thyroidectomy and radio-
therapy are effective for local tumor control; however,
chemotherapy is necessary in aggressive, disseminated
disease. In both retrospective studies of thyroid lym-
phoma4,8,21 and prospective studies of extranodal lym-
phoma,22,23 more favorable survival was achieved through
combined radiotherapy than through a single treatment.
However, a limitation of these studies is the lack of dif-
ferentiation among histological subtypes of thyroid lym-
phoma. DLBCL usually presents as a more aggressive and
disseminated disease, whereas MALT lymphoma tends to be
localized.2,10 Localized treatment through surgery or
radiotherapy produces satisfactory results for early-stage
MALT lymphoma.24e26 Radiotherapy alone can deliver
excellent long-term relapse-free survival in stage I and II
thyroid MALT lymphoma.27 Moreover, no clear survival
benefit is yielded when chemotherapy is used for MALT
lymphoma.28 The outcomes of large cells or high-grade
malignant cells admixed with MALT lymphoma are similar
to or poorer than those of pure diffuse large-cell-subtype
lymphoma. In such cases, a more aggressive treatment
should be used.2,29 The complete surgical resection of the
thyroid can exclude this possibility. In Patient 5, total
thyroidectomy was performed despite a previous patho-
logical diagnosis of MALT lymphoma. The reasons for
removing the remaining thyroid tissue were both to estab-
lish a definitive diagnosis and to cure the localized lym-
phoma. Because high-grade malignancies were excluded by
pathology, the patient underwent adjuvant radiotherapy
instead of chemotherapy. No recurrence was observed
after 107 months of follow-up, consistent with favorable
outcomes expected from surgical treatments of MALT
lymphoma.24,30
From our experiences of surgeries involving thyroid
lymphoma, we suggest thyroidectomy in localized, stage I
or II MALT lymphoma, but not in any stage of DLBCL,
because the infiltrative nature of large B cell lymphoma
puts the recurrent laryngeal nerve at risk. Because deter-
mining histological subtypes is useful for treatment plan-
ning, effective biopsy is crucial. Additionally, CT should be
performed before operation in patients requiring thyroid-
ectomy in order to evaluate resectability.
The airway obstruction caused by thyroid lymphomas re-
quires urgent treatment. Endotracheal-tube insertion or
tracheostomy is the first step to securing the airway in an
emergency situation,31 followed by definite treatment.
Radiotherapy alone with pulse-steroid therapy can induce
tumor necrosis and shrinkage.32 Once DLBCL is confirmed
through biopsy, airway compression can be further relieved
using a combination of steroid, chemotherapy, and radio-
therapy. Thyroidectomy may also have an immediate
relieving effect on the airway obstruction31; however, com-
plete resection is usually impossible due to the infiltrating
tumor or extensive growth, posing a high risk of injury to the
recurrent laryngeal nerve or parathyroid glands.
Our experience suggests that effective biopsy is neces-
sary for the accurate histological diagnosis of thyroid lym-
phomas. In addition to surgical biopsy, ultrasound-guidedcore-needle biopsy is a safe and effective alternative.
When DLBCL is confirmed, the treatment of choice should
be combined chemoradiation instead of extensive surgery.
By contrast, MALT lymphoma tends to be localized and
could be treated using radiotherapy. Thyroidectomy may be
considered in resectable cases to exclude large-cell trans-
formation, which requires chemotherapy and worsens out-
comes. Consequently, the need for surgical treatment in
patients with primary thyroid lymphomas should depend on
the histological subtype and disease stage.References
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